title: [GVHD].
authors.affiliation: Department of Internal Medicine III, Akita University School of Medicine.
authors.forename: Makoto
authors.initials: M
authors.lastname: Hirokawa
authors.forename: Ikuo
authors.initials: I
authors.lastname: Miura
authors.forename: Ken-ichi
authors.initials: K
authors.lastname: Sawada
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D006086:Graft vs Host Disease / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use; D017893:Photopheresis; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D016559:Tacrolimus / Q000627:therapeutic use
chemical_list: D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D016572:Cyclosporine; D011239:Prednisolone; D016559:Tacrolimus; D008727:Methotrexate